Indivior PLC 8-K filings

Indivior is seeking shareholder approval for a revised Directors Remuneration Policy at its upcoming Annual General Meeting to attract and retain top talent, particularly in the competitive US biopharmaceutical market, and to align CEO compensation with shareholder value creation.

Indivior PLC announces the appointment of Joe Ciaffoni as CEO, along with several board changes and an amended agreement with Oaktree Capital Management.